Role of protein kinase C and NF-κB in proteolysis-inducing factor-induced proteasome expression in C2C12 myotubes
Open Access
- 6 April 2004
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (9) , 1850-1857
- https://doi.org/10.1038/sj.bjc.6601767
Abstract
Proteolysis-inducing factor (PIF) is a sulphated glycoprotein produced by cachexia-inducing tumours, which initiates muscle protein degradation through an increased expression of the ubiquitin–proteasome proteolytic pathway. The role of kinase C (PKC) in PIF-induced proteasome expression has been studied in murine myotubes as a surrogate model of skeletal muscle. Proteasome expression induced by PIF was attenuated by 4α-phorbol 12-myristate 13-acetate (100 nM) and by the PKC inhibitors Ro31-8220 (10 μM), staurosporine (300 nM), calphostin C (300 nM) and Gö 6976 (200 μM). Proteolysis-inducing factor-induced activation of PKCα, with translocation from the cytosol to the membrane at the same concentration as that inducing proteasome expression, and this effect was attenuated by calphostin C. Myotubes transfected with a constitutively active PKCα (pCO2) showed increased expression of proteasome activity, and a longer time course, compared with their wild-type counterparts. In contrast, myotubes transfected with a dominant-negative PKCα (pKS1), which showed no activation of PKCα in response to PIF, exhibited no increase in proteasome activity at any time point. Proteolysis-inducing factor-induced proteasome expression has been suggested to involve the transcription factor nuclear factor-κB (NF-κB), which may be activated through PKC. Proteolysis-inducing factor induced a decrease in cytosolic I-κBα and an increase in nuclear binding of NF-κB in pCO2, but not in pKS1, and the effect in wild-type cells was attenuated by calphostin C, confirming that it was mediated through PKC. This suggests that PKC may be involved in the phosphorylation and degradation of I-κBα, induced by PIF, necessary for the release of NF-κB from its inactive cytosolic complex.Keywords
This publication has 42 references indexed in Scilit:
- Proteolysis‐inducing factor regulates hepatic gene expression via the transcription factors NF‐κΒ and STAT3The FASEB Journal, 2001
- The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancerSurgery, 1999
- The Selective Protein Kinase C Inhibitor, Ro-31-8220, Inhibits Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) Expression, Induces c-Jun Expression, and Activates Jun N-terminal KinasePublished by Elsevier ,1996
- Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase CαCurrent Biology, 1996
- Protein kinase C inhibitors induce apoptosis in human malignant glioma cell linesFEBS Letters, 1994
- The mechanisms and treatment of weight loss in cancerProceedings of the Nutrition Society, 1992
- ATP‐dependent reversible association of proteasomes with multiple protein components to form 26S complexes that degrade ubiquitinated proteins in human HL‐60 cellsFEBS Letters, 1991
- Mutagenesis of the pseudosubstrate site of protein kinase C leads to activationEuropean Journal of Biochemistry, 1990
- Molecular cloning of cDNA for proteasomes from rat liver: primary structure of component C3 with a possible tyrosine phosphorylation siteBiochemistry, 1990
- Skeletal muscle metabolism in patients with malignant tumorPublished by Elsevier ,1976